Background
Methods
Task-oriented circuit training
Patients per group | 3 |
N. of therapists | 1 experienced physiotherapist |
Intensity (I) | I: 2 weeks, 5 days per week, 120 minutes |
Progression (P) | P: increasing the number of repetitions completed in 3 minutes at a workstation and increasing treadmill speed |
Exercises | Workstations: |
1: Step (the patient goes up and down a 20 cm step both with left and right foot) | |
2: Slalom (the patient kicks a ball walking through a slalom exercise, formed by 4 cones that are 1 m distant from each other) | |
3: Tandem exercise (the patient walks in tandem using a line as a guide. If he/she is not able to put one foot in front of the other, it is allowed to do a wider and longer step as long as it is challenging) | |
4: Goals (the patient must touch with the tip of the foot a goal that is positioned on a mirror in front of him. If necessary, he can use a lateral support) | |
5: Obstacles (the patient must pass 5 obstacles, 3 of which are 5 cm high) | |
6: Long step (the patient must walk performing long steps (at least 40-50 cm long) using some signs on the floor as a guide) | |
Subjects exercise for 3 minutes at each workstation followed by a 2 minutes break | |
7: Treadmill (the patient should walk up to 30 minutes at speed between 0.9 and 2.9 km/h. The speed is self selected by the subject, who can also take a break if she/he needs to) |
Home-based training program
Usual care (UC)
Outcome measures
10 Meter Walk Test (10MWT)
Six Minute Walk Test (SMWT)
Timed Up and Go test (TUG)
Dynamic Gait Index (DGI)
Fatigue Severity Scale (FSS)
Multiple Sclerosis Walking Scale – 12 (MSWS-12)
Multiple Sclerosis Impact Scale – 29 (MSIS-29)
Feasibility patient-reported questionnaire
Biostatistical analysis
Results
n | ||||
---|---|---|---|---|
All subjects | TOCT | UC | p value* | |
Total | 24 | 12 | 12 | |
Gender (male/female) | 7/17 | 5/7 | 2/10 | 0.18 |
MS type | 0.56 | |||
RR | 6 | 4 | 2 | |
PP | 10 | 5 | 5 | |
SP | 8 | 3 | 5 | |
Mean (SD) median
| ||||
All subjects
|
TOCT
|
UC
|
p value**
| |
Age (years) | 52.58 (11.21) | 49.92 (7.51) | 55.25 (13.82) | 0.16 |
53.50 | 51.5 | 58 | ||
MS duration (years) | 15.21 (8.68) | 12.16 (6.91) | 18.25 (9.46) | 0.09 |
15 | 10 | 18 | ||
EDSS score | 4.89 (0.54) | 4.95 (0.61) | 4.83 (0.49) | 0.56 |
5 | 5 | 4.75 |
Functional tests (walking endurance, speed, balance, mobility)
TOCT (n=12) | UC (n=12) | |||||
---|---|---|---|---|---|---|
Mean (SD) | Median (25th-75th Percentile) | 95% CI | Mean (SD) | Median (25th-75th Percentile) | 95% CI | |
SMWT (m) | ||||||
Pre- TOCT | 290.67 (72.92) | 283.40 (215.70 – 355.6) | 244.33 – 337 | 285.72 (79.15) | 298.40 (230.00 – 329.80) | 235.42 – 336.01 |
Post- TOCT | 310.72 (73.73) | 316.20 (237.50 – 371.60) | 263.87 – 357.57 | 275.77 (70.65) | 293.40 (227.80 – 333) | 230.88 – 320.66 |
3 months follow-up | 301.03 (72.58) | 308.50 (230.80 – 359.80) | 254.92 – 347.15 | 258.73 (100.80) | 274.30 (167.8 – 312.8) | 194.69 – 322.78 |
TUG (s) | ||||||
Pre- TOCT | 10.64 (2.48) | 9.89 (9.06 – 11.85) | 9.06 – 12.21 | 12.10 (4.00) | 11.19 (9.24 – 15) | 9.56 – 14.63 |
Post- TOCT | 10.05 (1.89) | 9.55 (8.56 – 10.93) | 8.85 – 11.25 | 12.23 (3.78) | 11.61 (9.27 – 14.07) | 9.82 – 14.63 |
3 months follow-up | 10.50 (2.03) | 9.56 (9.08 – 11.98) | 9.20 – 11.78 | 12.43 (3.92) | 12.25 (9.89 – 14.22) | 9.94 – 14.93 |
10MWT (m/s) | ||||||
Pre- TOCT | 1.08 (0.23) | 1.11 (0.94 – 1.20) | 0.94 – 1.23 | 1.03 (0.30) | 0.99 (0.77– 1.19) | 0.84 – 1.22 |
Post- TOCT | 1.13 (0.24) | 1.10 (1.00 – 1.29) | 0.98 – 1.28 | 1.02 (0.23) | 1.03 (0.81 – 1.15) | 0.87 – 1.16 |
3 months follow-up | 1.15 (0.19) | 1.19 (1.01 – 1.30) | 1.02 – 1.27 | 0.99 (0.30) | 0.87 (0.82 – 1.14) | 0.80 – 1.19 |
DGI | ||||||
Pre- TOCT | 16.83 (3.56) | 17 (15.5 – 19.5) | 14.57 – 19.10 | 14.75 (4.92) | 14 (12.5 – 18) | 11.62 – 17.88 |
Post - TOCT | 17.67 (3.11) | 18 (16 – 20) | 15.69 – 19.65 | 14.75 (4.14) | 16 (12 – 18) | 12.12 – 17.38 |
3 months follow-up | 17.75 (3.93) | 18 (14.5 – 10.5) | 15.25 – 20.25 | 13.75 (3.86) | 14 (11.5 – 17) | 11.29 – 16.21 |
Patient-reported questionnaires (fatigue, walking ability, health-related quality of life)
TOCT (n = 12) | UC (n = 12) | |||||
---|---|---|---|---|---|---|
Mean (SD) | Median (25th-75th percentile) | 95% CI | Mean (SD) | Median (25th-75th Percentile) | 95% CI | |
MSIS-29 Psy (0-100) | ||||||
Pre- TOCT | 51.66 (20.61) | 53.33 (32.22 – 64.44) | 38.57 – 64.76 | 49.44 (20.12) | 38.88 (36.11 – 72.22) | 36.65 – 62.23 |
Post- TOCT | 41.85 (15.73) | 42.22 (30.00 – 46.66) | 31.85 – 51.85 | 53.14 (19.24) | 47.77 (40.00 – 72.77) | 40.92 – 65.37 |
3 months follow-up | 42.96 (16.20) | 43.33 (29.44 – 56.11) | 32.66 – 53.25 | 53.70 (16.43) | 50.00 (42.77 – 65.00) | 43.26 – 64.14 |
MSIS-29 Phys (0-100) | ||||||
Pre- TOCT | 50.83 (15.60) | 53.00 (45.50 – 63.50) | 40.92 – 60.74 | 51.58 (18.67) | 50.00 (36.25 – 68.50) | 39.71 – 63.44 |
Post- TOCT | 44.41 (11.32) | 43.00 (39.25 – 50.50) | 37.22 – 51.61 | 53.75 (18.10) | 52.00 (38.50 – 70.25) | 42.24 – 65.25 |
3 months follow-up | 49.16 (11.00) | 48.00 (41.25 – 58.25) | 42.17 – 56.15 | 53.00 (22.28) | 49.00 (37.00 – 71.50) | 38.83 – 67.16 |
MSWS-12 (0-100) | ||||||
Pre- TOCT | 63.06 (14.00) | 66.67 (57.50 – 71.67) | 54.16 – 71.95 | 61.94 (18.28) | 60 (47.5 – 76.67) | 50.33 – 73.56 |
Post- TOCT | 52.36 (14.06) | 53.33 (42.5 – 62.5) | 43.43 – 61.29 | 70.83 (17.08) | 75 (55 – 82.5) | 59.98 – 81.68 |
3 months follow-up | 65.42 (16.04) | 63.33 (55 – 76.67) | 55.23 – 75.61 | 71.11 (20.34) | 74.17 (55.83 – 88.33) | 58.19 – 84.04 |
FSS | ||||||
Pre- TOCT | 5.43 (1.23) | 5.22 (4.94 – 6.50) | 4.65 – 6.22 | 5.79 (0.98) | 6.22 (4.77 –6.55) | 5.17 – 6.42 |
Post- TOCT | 5.05 (1.52) | 5.44 (4.59 – 6.11) | 4.09 – 6.02 | 6.11 (0.68) | 6.11 (5.44 – 6.78) | 5.68 – 6.54 |
3 months follow-up | 5.63 (0.78) | 5.78 (5.09 – 6.17) | 5.13 – 6.13 | 6.01 (0.91) | 6.28 (5.22 – 7) | 5.51 – 6.66 |